The Two Faces of Relaxin in Cancer: Antitumor or Protumor?

Hepatology. 2020 Mar;71(3):1117-1119. doi: 10.1002/hep.30998.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Liver Neoplasms*
  • Relaxin*
  • Xenograft Model Antitumor Assays

Substances

  • Relaxin